Lopinavir/ritonavir (LPV/r) pellets are a new formulation of a pediatric HIV medicine. The LPV/r Pellet Toolkit provides information on how to implement rollout of LPV/r pellets into the national health care system in the Rollout Planning and Management section. The toolkit also provides clinical information on LPV/r pellets in the Health Care Worker section, including recommendations on dosing and administration of the medication, as well as resources for working with caregivers.

The global AIDS response is at a precarious point—partial success in saving lives and stopping new HIV infections is giving way to complacency. At the halfway point to the 2020 targets, the pace of progress is not matching the global ambition. This report is a wake-up call—action now can still put us back on course to reach the 2020 targets.

UNAIDS has just launched a new initiative to highlight the imperative need to treat people with respect and dignity in order to achieve positive social change, including ending the AIDS epidemic by 2030.